BANK OF AMERICA CORP /DE/ - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 202 filers reported holding MYRIAD GENETICS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$48,084,663
-30.2%
2,997,797
+0.9%
0.01%
-28.6%
Q2 2023$68,863,631
-13.6%
2,970,821
-13.5%
0.01%
-12.5%
Q1 2023$79,747,869
+107.5%
3,432,969
+29.6%
0.01%
+100.0%
Q4 2022$38,440,633
-29.4%
2,649,251
-7.2%
0.00%
-42.9%
Q3 2022$54,454,000
+9.4%
2,853,903
+4.2%
0.01%
+16.7%
Q2 2022$49,775,000
-28.4%
2,739,422
-0.7%
0.01%
-14.3%
Q1 2022$69,531,000
+1.2%
2,759,204
+10.8%
0.01%0.0%
Q4 2021$68,705,000
-17.8%
2,489,317
-3.8%
0.01%
-22.2%
Q3 2021$83,538,000
+10.0%
2,587,125
+4.1%
0.01%
+12.5%
Q2 2021$75,977,000
-9.1%
2,484,514
-9.5%
0.01%
-11.1%
Q1 2021$83,613,000
+62.8%
2,745,901
+5.7%
0.01%
+28.6%
Q4 2020$51,366,000
+87.1%
2,597,584
+23.4%
0.01%
+75.0%
Q3 2020$27,455,000
+15.4%
2,105,429
+0.4%
0.00%0.0%
Q2 2020$23,784,000
+32.5%
2,097,403
+67.2%
0.00%
+33.3%
Q1 2020$17,949,000
+1262.9%
1,254,327
+2493.6%
0.00%
Q4 2019$1,317,000
-19.5%
48,363
-15.4%
0.00%
Q3 2019$1,637,000
-65.8%
57,137
-66.9%
0.00%
-100.0%
Q2 2019$4,793,000
-8.8%
172,516
+8.9%
0.00%0.0%
Q1 2019$5,258,000
+166.8%
158,381
+133.6%
0.00%
Q4 2018$1,971,000
+66.0%
67,796
+162.7%
0.00%
Q3 2018$1,187,000
-58.4%
25,803
-66.2%
0.00%
Q2 2018$2,856,000
+34.8%
76,438
+6.7%
0.00%
Q1 2018$2,118,000
+7.6%
71,626
+25.0%
0.00%
Q4 2017$1,968,000
-65.5%
57,298
-63.7%
0.00%
-100.0%
Q3 2017$5,708,000
+62.2%
157,756
+15.8%
0.00%0.0%
Q2 2017$3,519,000
+8.0%
136,179
-19.7%
0.00%0.0%
Q1 2017$3,257,000
-73.4%
169,669
-76.9%
0.00%
-50.0%
Q4 2016$12,225,000
+967.7%
733,310
+1218.7%
0.00%
Q3 2016$1,145,000
-59.4%
55,608
-39.7%
0.00%
-100.0%
Q2 2016$2,821,000
-25.8%
92,163
-9.3%
0.00%0.0%
Q1 2016$3,802,000
-29.2%
101,567
-18.4%
0.00%0.0%
Q4 2015$5,370,000
+86.7%
124,404
+62.2%
0.00%0.0%
Q3 2015$2,876,000
-48.6%
76,715
-53.4%
0.00%
-50.0%
Q2 2015$5,596,000
+72.6%
164,620
+79.7%
0.00%
+100.0%
Q1 2015$3,242,000
-19.9%
91,593
-22.9%
0.00%0.0%
Q4 2014$4,046,000
-41.0%
118,777
-33.2%
0.00%
-50.0%
Q3 2014$6,854,000
-60.7%
177,720
-60.3%
0.00%
-66.7%
Q2 2014$17,429,000
-43.1%
447,799
-50.0%
0.01%
-45.5%
Q1 2014$30,643,000
+605.6%
896,261
+333.0%
0.01%
+1000.0%
Q4 2013$4,343,000
-71.7%
206,986
-68.3%
0.00%
-83.3%
Q3 2013$15,353,000
+46.1%
653,294
+67.1%
0.01%
+50.0%
Q2 2013$10,506,000391,0080.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders